Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants
开发一种基于耐热SARS-CoV-2变异株的二价蛋白疫苗,该疫苗对Omicron亚型具有交叉中和效力
期刊:Virology
影响因子:2.8
doi:10.1016/j.virol.2022.09.003
Rui Wang,Xun Huang,Tianshu Cao,Chunyun Sun,Dan Luo,Hongying Qiu,Mei Wu,Xingyao Huang,Chulin Yu,Jing Li,Desheng Kong,Juan Ma,Xiao Zhang,Ping Hu,Yanjing Zhang,Chunxia Luo,Hui Zhao,Yuchang Li,Yongqiang Deng,Chengfeng Qin,Liangzhi Xie